Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody

T3/4.A is a non-mitogenic murine IgA mAb to human CD3 that was selected for clinical studies to provide an alternative for the mitogenic, T cell-activating, therapeutic mAb OKT3. Previously, we reported that T3/4.A is better tolerated in humans than the IgG2a-CD3 mAb T3/4.2a. Here we report the resu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: MEIJER, R T, SURACHNO, S, YONG, S L, BEMELMAN, F J, FLORQUIN, S, TEN BERGE, I J M, SCHELLEKENS, P T A
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2003
Assuntos:
Clinical Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1808785/
https://ncbi.nlm.nih.gov/pubmed/12930378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2249.2003.02200.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados